(Q40630001)

22 September 2017

The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors (English)

1 reference

22 September 2017

2

Trever G Bivona

1 reference

22 September 2017

Luping Lin

1

1 reference

PMCID

4845171

22 September 2017

language of work or name

1 reference

27 April 2015

1 reference

Molecular & cellular oncology

22 September 2017

1 reference

22 September 2017

3

1 reference

22 September 2017

1

1 reference

22 September 2017

e1021441

1 reference

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

The emerging roles of YAP and TAZ in cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Genetics and biomarkers in personalisation of lung cancer treatment

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Circumventing cancer drug resistance in the era of personalized medicine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4845171

Reliable and effective diagnostics are keys to accelerating personalized cancer medicine and transforming cancer care: a policy statement from the american association for cancer research

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27308535

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/23723556.2015.1021441

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

PMCID

4845171